<i>In silico</i> design of novel indolinone-based anticancer agents and proposal of synthetic routes. [PDF]
Er-Rajy M +8 more
europepmc +1 more source
Structure-Guided Design of a Subnanomolar Dengue Virus NS4B Inhibitor. [PDF]
Laorsatiankul P +9 more
europepmc +1 more source
Validation Strategy Dominates Model Choice in Chronological QSAR Evaluation. [PDF]
Almendra F, Falcao AO.
europepmc +1 more source
Molecular modeling design of antitrypanosomal pyrazolone derivatives targeting Chagas disease: QSAR, docking, molecular dynamics and free energy calculations. [PDF]
Sousa KKF +4 more
europepmc +1 more source
A Nano-QSAR Model for the Cytotoxicity of Doxorubicin Prodrug Micelles in Multidrug-Resistant Cancer Cells. [PDF]
Kurian S, Santiago R.
europepmc +1 more source
MMP2Mol: a matched molecular pairs-based framework for ligand-based de novo drug design. [PDF]
Chen D +5 more
europepmc +1 more source
Quantitative Structure-Activity Relationship Approaches for Exploring the Anticancer Potential of Flavonoids. [PDF]
Gupta M +4 more
europepmc +1 more source
Modeling the Soil Dissipation Kinetics of Small Molecules. [PDF]
Scholz VA +5 more
europepmc +1 more source
Teaching computational toxicology as new approach methodologies in the era of next-generation risk assessment. [PDF]
Liu S +7 more
europepmc +1 more source
Beyond the Score: Fixed-Budget Benchmarking of Virtual Screening Integration Strategies for Decision-Centric Drug Discovery. [PDF]
Tomarchio EG, Buccheri R, Rescifina A.
europepmc +1 more source

